Canadian generic drug market to reach C$9.4 billion by 2013
Canadian generic drug sector represents one of the fastest growing opportunities in the pharmaceutical industry. In 2009, the generic drugs market reached to the mark of C$5.47 billion backed by factors like, patent expiration of branded drugs and government support through cost-cutting measures.
The research report has found that cardiovascular drug market is one of the most vibrant sectors in Canadian pharmaceutical industry.
Both the prescription and sales related to cardiovascular drugs have been increasing and given the fact that, many drugs will lose their patents in future, the market is expected to grow further, said the research firm.
In 2009, the total sales of cardiovascular drugs reached C$3.3 billion, which is expected to be worth around C$4.1 billion by 2013. The report has also covered current market trends that have had a positive impact on the sector recently and that are expected to back the sector in near future.
Have your say and discuss with your peers on the InfoGrok community.
Participate by posting your comments now.